je.st
news
Home
› IncellDx Signs Agreement With Bristol-Myers Squibb Related To The Development Of An Assay For A Companion Diagnostic Test
IncellDx Signs Agreement With Bristol-Myers Squibb Related To The Development Of An Assay For A Companion Diagnostic Test
2013-10-30 05:49:33| drugdiscoveryonline News Articles
IncellDx, Inc. announced today that they have entered into an agreement with Bristol-Myers Squibb Company (NYSE:BMY) related to the development of an assay for potential application in a molecular companion diagnostic intended to identify patients likely to benefit from treatment with a Bristol-Myers Squibb drug that is currently under development
Tags: related
development
test
agreement
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||